COMMITMENTS AND CONTINGENCIES (Details Narrative) |
5 Months Ended |
|---|---|
|
Dec. 31, 2025
USD ($)
shares
| |
| Loss Contingencies [Line Items] | |
| Proceeds of the proposed offering | $ 7,500,000 |
| Maximum [Member] | |
| Loss Contingencies [Line Items] | |
| Proceeds of the proposed offering | 8,625,000 |
| Sought value | $ 15,000,000 |
| Over-Allotment Option [Member] | |
| Loss Contingencies [Line Items] | |
| Sale of units in initial public offering | shares | 3,750,000 |
| Cash underwriting discount | $ 1,000,000 |
| IPO [Member] | |
| Loss Contingencies [Line Items] | |
| Deferred fee percentage | 3.00% |
| X | ||||||||||
- Definition Cash underwriting discount. No definition available.
|
| X | ||||||||||
- Definition Deferred underwriting discount. No definition available.
|
| X | ||||||||||
- Definition Deferred underwriting discount percentage. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|